Has Peter Sunenshine, MD received payments from drug or device companies?

Yes. Drug and device makers reported $50,978 in general payments to Peter Sunenshine, MD across 168 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Sunenshine, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Sunenshine, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Sunenshine, MD

Neuroradiology · Redding, CANPI 1487610937

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 57.2% of the total. Among neuroradiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,978in general payments, 2019–2025

Across 168 payments — averaging $303.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$29K
Single Pass Inc$15K
Imperative Care, Inc$2K
Penumbra, Inc.$893
Johnson & Johnson$723
Stryker$490
plus $3K from 20 others

$90,722in research payments, 2019–2025

Across 45 payments — averaging $2016.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$32K
Microvention, Inc.$30K
Penumbra, Inc.$29K

What the payments were for

Consulting fees$15,12030%
Speaking & faculty fees$27,82055%
Travel & lodging$1,2032%
Food & beverage$6,83513%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	49	$29,176
Single Pass Inc	2	$15,120
Imperative Care, Inc	43	$2,011
Penumbra, Inc.	13	$893
Johnson & Johnson(2 entities)	15	$723
Stryker	5	$490
Microvention, Inc.	8	$489
Route 92 Medical, Inc.	3	$335
Relievant Medsystems, Inc.	5	$326
Balt USA, LLC	2	$308
Rapid Medical Ltd	2	$295
Phenox Inc.	1	$200
AbbVie	2	$181
Okami Medical, Inc.	1	$69
Biogen	2	$58
Bard Peripheral Vascular, Inc.	1	$45
Mallinckrodt Enterprises LLC	2	$43
Eisai Inc.	2	$36
Biosense Webster, Inc.	2	$35
Terumo Medical Corporation	2	$30
Abbott	1	$29
Neurocrine Biosciences, Inc.	1	$25
Siemens Medical Solutions USA, Inc.	1	$24
EKOS Corporation	1	$14
Boston Scientific	1	$13
Cardinal Health 200 LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Pipeline$28,629
Kronos$15,120
SURPASS$318
CATALYST$318
TIGERTRIEVER 17 REVASCULARIZATION DEVICE$295
COMANECI 17$295
ZOOM 88-T LARGE DISTAL PLATFORM$279
Penumbra System$270
TracStarLargeDistalPlatform$241
Zoom88LargeDistalPlatform$241
Zoom88_TLargeDitalPlatform$241
ZoomReperfusionCatheter$241
8F Base Camp Sheath System$231
Optima Coil System$209
Intracept$200
Avenir Coils$200
Smart Coil$170
ZOOM REPERFUSION CATHETER$158
Smart$150
INFINITY$149

How this compares

$50,978 in reported general payments places this provider in the 90th percentile of 154 neuroradiology providers in California.

See all neuroradiology providers in California →

Medicare billing

Part B allowed, 2024

$152,813

Medicare patients

541

Services billed

1,351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	27	$102

Paid to pharmacies, not to this prescriber.

Other neuroradiology in Redding

Aaron BerezMountain View$24.1M
Amon LiuRedwood City$1.1M
Fabio SettecaseSan Francisco$758K
Michael MarksStanford$254K
Huy DoStanford$226K
Akash KansagraStanford$179K
Bradley JabourSanta Monica$156K
Christopher PutmanTorrance$148K
Nicholas TelischakStanford$148K
Jay AcharyaWest Hollywood$128K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →